FDA officials call for patient-friendly terminology in oncology
from Regulatory Affairs Professionals Society
In a paper published recently in The Oncologist, officials from FDA's Oncology Center of Excellence and Office of Hematology and Oncology Products make the case for working with patients and patient advocacy groups to develop resources to help patients understand the complex and nuanced terminology they are often faced with when making treatment decisions.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063